Protea Announces Research Agreement with Mass General Hospital – Markets Insider
|
Protea Announces Research Agreement with Mass General Hospital
Markets Insider MORGANTOWN, W. Va, Aug. 8, 2017 /PRNewswire/ — Protea Biosciences Group, Inc. (OTCQB: PRGB) (‘Protea’) announced today that it had entered into a … |
|
TIMELINE-Gene therapy’s long road to market
Reuters LONDON, Aug 8 (Reuters) – Gene therapy, which aims to patch faulty genes with working DNA, has been a long time in development. The following are major milestones: 1972 – Researchers first suggest gene therapy as a treatment for genetic diseases but … |
|
Timeline: Gene therapy’s long road to market
Reuters LONDON (Reuters) – Gene therapy, which aims to patch faulty genes with working DNA, has been a long time in development. The following are major milestones: 1972 – Researchers first suggest gene therapy as a treatment for genetic diseases but oppose … |
eNCA |
Drugmakers’ hopes for gene therapy rise despite tiny sales in Europe
eNCA After decades of frustrations, firms believe there are now major opportunities for gene therapy in treating inherited conditions such as haemophilia. They argue that therapies offering one-off cures for intractable diseases will save health providers … |